Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ryman Healthcare Limited (RYM.NZ)
NZD2.16
+0.02 (+0.93%)
NZ NZE Healthcare Medical - Care Facilities
Address
Airport Business Park 8042
Christchurch, NZ
Christchurch, NZ
CEO
Naomi James
Website
rymanhealthcare.co.nz
IPO
2000-01-04
ISIN NZRYME0001S4
Also trades on
Australian Securities Exchange · RYM.AX (AUD)
New Zealand Exchange · RYM.NZ (NZD)
Other OTC · RHCGF (USD)
Other OTC · RYHTY (USD)
Description
Ryman Healthcare Limited, established in Christchurch, New Zealand, in 1984, specializes in the development, ownership, and management of all-encompassing retirement communities for seniors. Operating across both New Zealand and Australia, the company provides a wide array of living and care solutions. These range from independent townhouses and apartments to serviced accommodations, complemented by dedicated care facilities offering residential, hospital, and specialized dementia care, alongside respite and day care services. Each of these integrated villages is equipped with extensive amenities, including indoor heated swimming pools, fitness centers, libraries, dining rooms, internet cafes, bars, retail outlets, movie theaters, bowling greens, and beauty and hairdressing salons. As of May 20, 2022, Ryman Healthcare oversaw 45 retirement villages, encompassing roughly 8,538 independent living units and 4,239 care beds.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
NZD2.16
+0.02 (+0.93%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.35
Float Shares
850.82M
Free Float %
83.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.90% | +11.44% | -1.75% | -9.68% | -21.68% | -23.02% | -9.68% | -62.85% | -82.62% | -75.33% | +768.15% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2.16
DCF (Levered)
13.31
+516.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | -2 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.42
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+11.9% ★ Q1'26: +22.7% (vs Q1'24)
-
EPS growth Medical - Care Facilities: +19.2%+72.6% ★ Q1'26: +53.8% (vs Q1'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+31.3% ★ Q1'26: +30.9% (vs Q1'24)
-
EBIT margin Medical - Care Facilities: +11.3%-2.2% Q1'26: -1.9% (vs Q1'24)
-
ROIC Medical - Care Facilities: +6.8%-0.3% Q1'26: -0.5% (vs Q1'24)
-
Share dilution Medical - Care Facilities: +0.0%+43.0% Q1'26: +47.6% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×64.21× Q1'26: 31.03× (vs Q1'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 3 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. |
Mar 2030 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
225.77M
est: 332.57M (-32.1%)
|
260.06M
est: 323.23M (-19.5%)
|
288.38M
est: 477.01M (-39.5%)
|
340.57M
est: 415.14M (-18.0%)
|
380.95M
est: 482.04M (-21.0%)
|
422.11M
est: 529.52M (-20.3%)
|
452.41M
est: 552.22M (-18.1%)
|
503.76M
est: 664.78M (-24.2%)
|
560.11M
est: 738.88M (-24.2%)
|
650.53M
est: 930.64M (-30.1%)
|
713.80M
est: 907.21M (-21.3%)
|
865.10M
830.11M – 901.07M
-4.6% YoY
|
945.10M
902.79M – 1.00B
+9.2% YoY
|
1.00B
917.09M – 1.11B
+6.0% YoY
|
996.00M
983.58M – 1.01B
-0.5% YoY
|
1.05B
1.01B – 1.12B
+5.8% YoY
|
| EBITDA |
261.15M
est: 156.76M (+66.6%)
|
329.81M
est: 152.35M (+116.5%)
|
388.58M
est: 224.84M (+72.8%)
|
426.01M
est: 195.68M (+117.7%)
|
371.50M
est: 227.21M (+63.5%)
|
219.07M
est: 249.59M (-12.2%)
|
462.23M
est: 260.29M (+77.6%)
|
788.44M
est: 313.34M (+151.6%)
|
264.80M
est: 348.27M (-24.0%)
|
-50.73M
est: 438.65M (-111.6%)
|
-27.16M
est: 427.61M (-106.4%)
|
407.76M
391.27M – 424.72M
-4.6% YoY
|
445.47M
425.53M – 471.38M
+9.2% YoY
|
472.04M
432.27M – 523.71M
+6.0% YoY
|
469.46M
463.61M – 475.31M
-0.5% YoY
|
496.80M
474.56M – 525.69M
+5.8% YoY
|
| EBIT |
251.63M
est: 138.91M (+81.1%)
|
318.86M
est: 135.01M (+136.2%)
|
373.65M
est: 199.25M (+87.5%)
|
405.43M
est: 173.40M (+133.8%)
|
348.37M
est: 201.35M (+73.0%)
|
190.21M
est: 221.18M (-14.0%)
|
429.49M
est: 230.66M (+86.2%)
|
752.54M
est: 277.67M (+171.0%)
|
411.38M
est: 308.63M (+33.3%)
|
-94.53M
est: 388.72M (-124.3%)
|
-75.62M
est: 378.94M (-120.0%)
|
361.35M
346.73M – 376.37M
-4.6% YoY
|
394.76M
377.09M – 417.72M
+9.2% YoY
|
418.31M
383.07M – 464.10M
+6.0% YoY
|
416.02M
410.84M – 421.21M
-0.5% YoY
|
440.25M
420.54M – 465.86M
+5.8% YoY
|
| Net Income |
241.92M
est: 178.07M (+35.9%)
|
305.42M
est: 197.43M (+54.7%)
|
356.69M
est: 201.43M (+77.1%)
|
388.22M
est: 251.78M (+54.2%)
|
325.99M
est: 285.63M (+14.1%)
|
264.71M
est: 312.96M (-15.4%)
|
423.06M
est: 288.29M (+46.7%)
|
692.87M
est: 287.46M (+141.0%)
|
257.84M
est: 345.49M (-25.4%)
|
4.78M
est: 264.41M (-98.2%)
|
-436.83M
est: 130.63M (-434.4%)
|
5.37M
5.02M – 5.73M
-95.9% YoY
|
53.43M
49.88M – 56.97M
+894.1% YoY
|
79.59M
74.31M – 84.88M
+49.0% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| SGA |
118.30M
est: 177.56M (-33.4%)
|
133.33M
est: 172.57M (-22.7%)
|
149.30M
est: 254.68M (-41.4%)
|
179.56M
est: 221.65M (-19.0%)
|
212.51M
est: 257.36M (-17.4%)
|
233.55M
est: 282.72M (-17.4%)
|
265.49M
est: 294.84M (-10.0%)
|
305.76M
est: 354.93M (-13.9%)
|
—
est: 394.50M (-100.0%)
|
463.91M
est: 496.88M (-6.6%)
|
544.35M
est: 484.37M (+12.4%)
|
461.89M
443.20M – 481.09M
-4.6% YoY
|
504.59M
482.01M – 533.94M
+9.2% YoY
|
534.69M
489.64M – 593.22M
+6.0% YoY
|
531.77M
525.14M – 538.40M
-0.5% YoY
|
562.74M
537.55M – 595.47M
+5.8% YoY
|
| EPS |
0.46
est: 0.25 (+83.5%)
|
0.58
est: 0.28 (+108.6%)
|
0.67
est: 0.28 (+136.2%)
|
0.73
est: 0.35 (+105.9%)
|
0.61
est: 0.40 (+51.7%)
|
0.50
est: 0.44 (+13.5%)
|
0.80
est: 0.41 (+97.1%)
|
1.31
est: 0.40 (+223.6%)
|
0.50
est: 0.49 (+2.8%)
|
0.01
est: 0.37 (-98.1%)
|
-0.62
est: 0.18 (-437.1%)
|
0.01
0.01 – 0.01
-95.9% YoY
|
0.07
0.07 – 0.08
+894.1% YoY
|
0.11
0.10 – 0.12
+49.0% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-25 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.49B
OE per share TTM
1.83
Owner's Yield
66.03%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
278.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 80 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI New Zealand ETF ENZL | 2.37% | 1.59M | 0.50% |
| 2 | Global X - Aging Population ETF AGNG | 0.30% | 254.1K | 0.50% |
| 3 | iShares Ageing Population UCITS ETF AGED.L | 0.10% | 927.3K | 0.40% |
| 4 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.04% | 356.6K | 0.23% |
| 5 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.04% | 356.7K | 0.23% |
| 6 | Dimensional - International Small Cap Value ETF DISV | 0.04% | 2.06M | 0.42% |
| 7 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.03% | 72.8K | 0.83% |
| 8 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.03% | 4.39M | 0.40% |
| 9 | Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF (USD) Accumulating VAPU.L | 0.02% | 739.6K | 0.15% |
| 10 | Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF (USD) Distributing VDPX.L | 0.02% | 739.6K | 0.15% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-2.3K
Shares Outstanding
1.02B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Naomi James | Chief Executive Officer | 1M | female |
| Marie Bonnemaison | Chief Transformation & Corporate Development Officer | — | female |
| Marsha E. Cadman | Chief Transformation & Strategy Officer and Chief Operating Officer | — | female |
| Matthew Thomas Prior | Chief Financial Officer | — | male |
| Rachna Gandhi | Chief Enterprise Strategy, Systems & Governance Officer | — | — |
| Richard Stephenson | Chief Development & Property Officer | — | male |
| Di Walsh | Chief People & Safety Officer | — | female |
| Rick Davies | Chief Customer Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RYM.NZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
